Jushi HoldingsJUSHF -1.13%47 Gross Margin % is 44.97% as of Mar. 2026, which is 4% above its 10-year median of 43.25. GuruFocus rates JUSHF with a GF Score™ of 47/100 and a GF Value™ of $0.51 (Fairly Valued). The stock has 5 warning signs investors should review. Among 935 Drug Manufacturers companies, Jushi Holdings ranks worse than 56.79% on this metric.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Jushi Holdings had a gross margin of 44.97% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Jushi Holdings Gross Margin % Related Terms
Jushi Holdings Gross Margin % Historical Data
* Premium members only.
The historical data trend for Jushi Holdings's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Jushi Holdings's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jushi Holdings Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Jushi Holdings's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Jushi Holdings's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Jushi Holdings (JUSHF) has a Gross Margin % of 44.97% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Jushi Holdings and its competitors. This is near median its historical median of 43.25. Over the past decade, Jushi Holdings' Gross Margin % has ranged from 33.59 to 47.47. According to the industry distribution chart, Jushi Holdings ranks #531 out of 935 companies in the Drug Manufacturers industry, placing it in the top 56.8%.
Is Jushi Holdings' Gross Margin % too high?
Jushi Holdings' current Gross Margin % of 44.97% is near median its 10-year median of 43.25. Over the past 10 years, this metric has ranged from a low of 33.59 to a high of 47.47. The Drug Manufacturers industry median Gross Margin % is 48.54. Jushi Holdings' value of 44.97% is 7.4% below this industry median. Based on the distribution chart, Jushi Holdings ranks #531 out of 935 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Jushi Holdings has a GF Score™ of 47/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Jushi Holdings' Gross Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Jushi Holdings ranks #531 out of 935 companies for Gross Margin %. This places Jushi Holdings in the lower half of its industry. The industry median Gross Margin % is 48.54. Jushi Holdings' value of 44.97% is 7.4% below this benchmark. Historically, Jushi Holdings' own Gross Margin % has ranged from 33.59 to 47.47 over the past decade. While the company's 10-year median is 43.25 vs. the industry median of 48.54, Jushi Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.54, based on 935 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jushi Holdings's current Gross Margin % of 44.97% is 7.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Jushi Holdings and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jushi Holdings's current Gross Margin % is 44.97%, which is near median its own 10-year median of 43.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jushi Holdings stock overvalued right now?
Based on GuruFocus' analysis, Jushi Holdings (JUSHF) is currently considered Fairly Valued. The stock's GF Value™ is $0.51, compared to a current price of $0.48 — trading 6% below its estimated fair value. The current Gross Margin % is 44.97%, which is near median its 10-year median of 43.25 and 7.4% below the Drug Manufacturers industry median of 48.54. Jushi Holdings' overall GF Score™ is 47/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Jushi Holdings (JUSHF), the current Gross Margin % is 44.97% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jushi Holdings (JUSHF) Overvalued in 2026?
Based on GuruFocus' analysis, Jushi Holdings stock appears to be undervalued.
The current stock price of $0.48 is trading 6% below its estimated GF Value™ of $0.51.
GuruFocus considers Jushi Holdings to be Fairly Valued.
Key valuation signals for JUSHF:
Gross Margin %: 44.97% (near median its 10-year median of 43.25)
GF Value™: $0.51 vs. price of $0.48 (6% below fair value)
Industry Position: 7.4% below the Drug Manufacturers median (#531 of 935)
No single metric tells the full story. See the JUSHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jushi Holdings Inc is a vertically integrated multi-state cannabis and hemp operator engaged in retail, distribution, cultivation, and processing in both medical and adult-use markets. The company operates a diverse portfolio of branded cannabis and hemp-derived assets built upon opportunistic acquisitions, distressed deals, and competitive applications. Its products are offered through brands like Hijinks, The Bank, The Lab, Seche, and Tasteology, among others. The company distributes its products through various retail dispensaries, including Nature's Remedy, Beyond Hello, and NuLeaf, and also operates an e-commerce platform called The Jushi Shop, offering branded apparel, accessories, and other products of its different brands. All of its revenues are generated within the United States.
47GF Score
Get the complete analysis for JUSHF
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JUSHF has been successfully added to your 
